FDA OKs Automatic Use of a Cheaper Generic   Insulin

THURSDAY, July 29, 2021 -- U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday. The agency ' s approval of an...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news